Linda M Kolb

Title: The Innovative Contributions of Linda M. Kolb

Introduction

Linda M. Kolb is a notable inventor based in Del Mar, California. She has made significant contributions to the field of biomedical research, particularly in the area of complement activation. Her work has implications for clinical sample storage and complement protein assays.

Latest Patents

Linda M. Kolb holds a patent titled "Prevention of spontaneous complement activation in mammalian biological." This patent describes the use of selected polyhydroxyl compounds, including monosaccharides, disaccharides, and oligosaccharides, as well as certain derivatives, to prevent spontaneous activation of complement in vitro. The effectiveness of these compounds is enhanced when combined with an anticoagulant and a divalent cation chelator. This innovation allows for the storage of clinical samples at conventional temperatures ranging from -20°C to +22°C for extended periods before performing complement protein assays. The selection of effective compounds is achieved through a screening protocol that utilizes immunoassays for complement fragments along with an algorithm for computing effectiveness. Additionally, these polyhydroxyl compounds provide similar protection from activation to coagulation proteins.

Career Highlights

Linda M. Kolb is associated with Quidel Corporation, where she continues to contribute to advancements in biomedical research. Her innovative work has garnered attention in the scientific community, highlighting her role as a leading inventor in her field.

Collaborations

Linda has collaborated with notable colleagues, including William P. Kolb and John D. Tamerius, further enhancing the impact of her research and innovations.

Conclusion

Linda M. Kolb's contributions to the prevention of spontaneous complement activation represent a significant advancement in biomedical research. Her innovative approach not only improves clinical sample storage but also enhances the accuracy of complement protein assays.